DeepMind spin-out's Series B, second-largest biotech round ever, funds its IsoDDE engine and a first in-house trial by end-2026
AI Drug Design
Arc Institute's 40B-parameter DNA foundation model predicts disease mutations and designs bacterial-scale genomes, the design-tool side of the biosecurity debate